Sino Biopharmaceutical unit to buy 5% in CT Tianqing
Sino Biopharmaceutical says its SBP Group will acquire a 5% equity interest in CT Tianqing for RMB4.48 billion at 19X LTM P/E.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.